Image source: Getty Images
What are ASX penny stocks?
Penny stocks are shares that typically trade for less than $1. Sometimes they swap hands for just a few cents – hence the name. On the Australian Securities Exchange, these stocks are usually found among micro-cap or early-stage companies, particularly in sectors like mining exploration, biotechnology, and emerging technologies.
The small end of the ASX is significant. Of the roughly 2,200 listed companies in 2026, estimates suggest around 900 to 1,000 trade below $1 at any given time, highlighting just how large the penny stock universe is. More broadly, Australia's market is heavily skewed toward smaller companies, with around 65% of listings valued under $100 million and the majority of IPOs coming from early-stage businesses1.
Penny stocks tend to be more volatile than larger, more established shares. Their prices can move significantly on relatively small amounts of news or trading activity. This can create opportunities for strong gains, but also increases the risk of sharp losses.
These micro-cap stocks can seem like a bargain. After all, some ASX shares trade for hundreds of dollars. But whether a stock is a bargain depends less on its share price and more on how that price reflects the company's future performance.
Although the low cost of penny stocks can suggest the potential for rapid growth, investing in them can be risky, with a higher chance of losses and, in some cases, corporate failure or dilution.
Why invest in them?
Stock trading or share dealing in young companies with low valuations or depressed share prices can deliver strong returns. In the Australian market, some companies have started as small-cap or penny stocks before growing into much larger businesses, particularly in the resources and technology sectors.
In favourable conditions, smaller companies can outperform their larger peers. This is often because they have greater growth potential and can benefit more from positive developments, such as a successful exploration result or a new product launch.
That said, the risks are significant. Many penny stocks have limited revenue and rely on raising capital to fund their operations, which can dilute existing shareholders. Their business models may still be unproven, and not all will succeed.
Just because a stock is trading cheaply does not mean it is a bargain. The actual share price is far less important than the company's ability to generate sustainable growth over time.
The key is to research and understand the path a small company may take to profitability, while recognising that there are likely to be setbacks and volatility along the way.
What to look for when buying micro-cap shares
Successful investors in penny shares tend to look beyond the share price and focus on a company's ability to grow and generate revenue over time. On the ASX, where many micro-cap companies are still in early stages, this means backing a clear investment case that can withstand share price volatility.
Key things investors often look for include:
- A strong growth story: This could be a new technology, unique business model, or valuable asset such as a mineral resource or intellectual property.
- Experienced management: Leadership with a track record of delivering on strategy and managing capital effectively can make a significant difference.
- A clear path to revenue: Many penny stocks are pre-revenue, so a credible plan for commercialisation and growth is essential.
- Balance sheet strength: Investors should assess available cash, spending rates, and the likelihood of future capital raisings that could dilute shareholders.
- Liquidity: Some stocks trade in low volumes, which can make it harder to buy or sell shares without impacting the price.
Ultimately, even early-stage companies need a pathway to profitability to deliver long-term shareholder value. Understanding how a business plans to get there is a key part of evaluating any micro-cap investment.
Top penny shares on the ASX
(Based on market capitalisation from high to low.)
| Company | Description |
| Nickel Industries Ltd (ASX: NIC) | Major low-cost nickel producer with significant mining and smelting operations in Indonesia, serving the EV battery and stainless steel markets |
| Brainchip Holdings Ltd (ASX: BRN) | The company behind the world's first commercial neuromorphic processor, which mimics the human brain to process data with efficiency and precision |
| Bubs Australia Ltd (ASX: BUB) | Leading producer of goat dairy products in Australia, including the only infant formula in the world based wholly on Australian goat milk |
Nickel Industries
Nickel Industries (ASX: NIC) has started 2026 strongly, with its share price rising nearly 15% early in the year and around 27% since December. The company, a major producer of nickel pig iron and a global developer of nickel assets, has benefited from improving sentiment alongside a rebound in nickel prices.
A key catalyst has been a strategic partnership with Sphere Corp, which values its ENC HPAL project at US$2.4 billion and includes a 10% stake sale and a landmark offtake agreement for nickel cathode. This deal marks Nickel Industries' entry into Western aerospace and aeronautical markets, expanding its global reach beyond traditional stainless steel demand.
Looking ahead, brokers see 2026 as a potentially transformative year. Bell Potter has lifted its price target to $1.30, implying around 36.8% upside, and forecasts earnings growth of 22% in 2026. Increased ore sales, strategic partnerships, and stronger nickel prices are expected to support continued growth.
Brainchip Holdings
Brainchip (ASX: BRN) is the company behind Akida, a neuromorphic processor designed to mimic the human brain and enable machine learning directly on-chip, without relying on the cloud. This approach aims to improve efficiency, reduce power consumption, and enhance data security by processing information locally.
The company operates across Australia, the US, and Europe, placing it within the fast-growing AI hardware space. However, the industry is increasingly dominated by major players such as Nvidia, making it more challenging for smaller companies to scale.
Recent results highlight both the opportunity and the risk. In 2025, Brainchip reported full-year revenue of around US$1.9 million — up roughly 374% year-on-year — but still posted a loss of about US$20 million. This reflects a broader trend heading into 2026, where early-stage AI hardware companies are achieving strong growth but remain unprofitable as they invest in commercialisation.
The share price has also been volatile, which is common for small-cap stocks in emerging and highly competitive sectors.
Overall, Brainchip offers exposure to early-stage AI innovation, but its future will depend on turning early revenue growth into sustainable profitability in a market increasingly led by global technology giants.
Bubs Australia
A leading producer of goat dairy products in Australia, Bubs (ASX: BUB) makes a range of premium infant nutrition and wellbeing products, including infant formula based wholly on Australian goat milk, as well as adult and specialist formulations.
Its products are sold in major supermarkets and pharmacies across Australia and exported to key markets such as the US and China, which have become important growth drivers.
Recent results point to improving momentum. In its latest half-year update in February 2026, Bubs reported revenue of $55.5 million (up from $48.5 million) and EBITDA of $4.4 million (up from $0.5 million), while maintaining its full-year guidance.
The US remains its largest and most profitable market, supported by expanding retail distribution, while China demand remains solid despite short-term inventory disruptions. Some brokers see value at current levels, with expectations that continued growth could support further upside.
Benefits of investing in ASX penny shares
Investing in penny shares entails significant risk, but when they turn out well, they can be seriously lucrative. Many blue-chip shares on the ASX today started life as micro-cap stocks. For example, Pro Medicus Limited (ASX: PME) was a penny stock trading for less than $0.30 in the early 2010s; as of 2026, it is a global leader in health imaging software with a market capitalisation of approximately $13 billion.
Buying early into a successful penny stock can provide significant financial benefits, provided investors continue to hold the shares as they grow in value.
It is also vital that other investors are willing to hold their shares, as it takes relatively few sellers to undermine confidence in a penny stock, which may then adversely impact its price.
Penny shares tend to be smaller companies, which comes with some advantages. It is easier for a small company to grow quickly. Larger companies eventually reach a growth rate ceiling. Penny stocks also offer ASX investors the opportunity to purchase large quantities of shares for relatively little outlay.
This means ASX investors can afford to invest across a range of penny stocks in different market sectors while balancing these high-risk investments in the context of a broader portfolio.
What are the risks?
Penny stocks are often cheaply priced for a reason. They may be unproven, or their prospects for long-term success are mixed. In the worst-case scenario, they may be vehicles utilised by con artists to trick unsuspecting investors.
Investors in penny stocks often believe a low stock price means greater potential for share price growth than shares with higher prices. This is erroneous. Market capitalisation is determined not just by the share price but the number of shares outstanding.
For example, a company worth $100 million could issue a million shares at $100 each or 100 million shares at $1 each. It is entirely up to the company.
Penny stocks tend to entail more risk than higher-priced shares. This is because:
- The companies behind penny stocks are usually small and have not yet proven they can endure and succeed
- Penny stocks can, at times, be the target of pump-and-dump schemes. These occur when cons invest in a penny stock and then hype it as the next hot investment. This hype can cause the stock price to rise, at which point the con sells their stocks for a profit and ceases promoting the company. The share price then takes a tumble, leaving later investors with significant losses
- Penny stocks are often thinly traded. This means there are fewer buyers and sellers in the market for them. So, there may not be enough buyer demand when an investor in a penny stock seeks to sell.
Buying penny stocks can appear to be an easy way of growing your money quickly. But penny stocks have a reputation for being speculative, and for good reason.
Are ASX penny shares a good investment?
Any ASX stock can be risky, but the risk associated with ASX penny stocks is even higher. They have significant upside growth potential but lack the stability of larger, more established stocks. Any investor in micro-cap or small-cap shares needs to be prepared for the possibility of losing all their money.
For this reason, investing in penny stocks tends to suit those comfortable taking on higher levels of risk. They may not be suitable for risk-averse investors.
Ultimately, whether ASX penny stocks are for you will depend on your financial situation and investment objectives. Any stock market investing entails an element of risk, which should be considered in the investment decision.
